STOCK TITAN
  1. Home
  2. Sec-filings
  3. SRTA
  4. [Form 4] Strata Critical Medical, Inc. Insider Trading Activity

Strata Critical Medical (SRTA) co-CEO receives PSU share awards

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Strata Critical Medical director and co-CEO Melissa M. Tomkiel reported equity compensation changes in Class A common stock. On July 30, 2026 she acquired 208,929 and 206,953 shares upon vesting of performance-based restricted stock units from March 8, 2024 and March 20, 2025 grants. On July 31, 2026 the issuer withheld 212,309 shares at $5.09 per share to satisfy tax withholding obligations related to the PSU vesting.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Tomkiel Melissa M.
Role Co-CEO and General Counsel
Type Security Shares Price Value
Tax Withholding Class A common stock, $0.0001 par value per share F3 212,309 $5.09 $1.08M
Grant/Award Class A common stock, $0.0001 par value per share F1 208,929 $0.00 $0.00
Grant/Award Class A common stock, $0.0001 par value per share F2 206,953 $0.00 $0.00
Holdings After Transaction: Class A common stock, $0.0001 par value per share — 2,096,347 shares (Direct)
Footnotes (3)
  1. F1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
  2. F2. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
  3. F3. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
PSU vesting from 2024 grant 208,929 shares Shares acquired July 30, 2026 from PSUs granted March 8, 2024
PSU vesting from 2025 grant 206,953 shares Shares acquired July 30, 2026 from PSUs granted March 20, 2025
Shares withheld for taxes 212,309 shares at $5.09 per share Shares withheld July 31, 2026 to satisfy tax withholding obligations on PSU vesting
performance-based restricted stock units ("PSUs") financial
"satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs")"
Compensation Committee financial
"acquired upon the certification of the Compensation Committee of the Issuer's Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
tax withholding obligations financial
"shares withheld by the Issuer to satisfy tax withholding obligations in connection"
Class A common stock financial
"security_title": "Class A common stock, $0.0001 par value per share"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Melissa Tomkiel report for SRTA?
Co-CEO Melissa Tomkiel reported PSU vesting and related tax withholding. She acquired 208,929 and 206,953 Class A shares from performance-based RSUs, and 212,309 shares were withheld at $5.09 per share to cover tax obligations.

Were Melissa Tomkiel’s SRTA transactions open-market buys or sells?
No. The SRTA transactions reflect equity awards and tax withholding, not open-market trading. Shares came from vesting performance-based RSUs, and 212,309 shares were withheld by the issuer to satisfy tax liabilities associated with that vesting event.

What performance-based RSUs vested for SRTA’s co-CEO Melissa Tomkiel?
Two PSU grants vested after performance criteria were certified. One from a March 8, 2024 grant delivered 208,929 shares, and another from a March 20, 2025 grant delivered 206,953 Class A common shares to Melissa Tomkiel.

How many SRTA shares were withheld to cover Melissa Tomkiel’s taxes?
To satisfy tax withholding obligations on the PSU vesting, the issuer withheld 212,309 shares of Class A common stock at a value of $5.09 per share, rather than selling shares on the open market.

Does this SRTA insider report indicate use of a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan. The reported transactions involve PSU vesting and tax withholding, rather than discretionary open-market trades under a pre-arranged trading program.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tomkiel Melissa M.
(Last)(First)(Middle)
C/O STRATA CRITICAL MEDICAL, INC.
666 THIRD AVENUE, 25TH FLOOR
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Co-CEO and General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A common stock, $0.0001 par value per share07/30/2026A208,929(1)A$02,101,703D
Class A common stock, $0.0001 par value per share07/30/2026A206,953(2)A$02,308,656D
Class A common stock, $0.0001 par value per share07/31/2026F212,309(3)D$5.092,096,347D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
2. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
3. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
Remarks:
/s/ Melissa M. Tomkiel08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR